Rhelion Life Sciences Corp (RHEL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 1,168 | 1,368 | 1,559 | 1,276 | 1,291 |
| Cost of Goods | 754 | 816 | 934 | 770 | 745 |
| Gross Profit | 415 | 552 | 625 | 506 | 546 |
| Operating Expenses | 1,402 | 1,285 | 2,265 | 2,218 | 1,871 |
| Operating Income | -987 | -733 | -1,641 | -1,712 | -1,325 |
| Interest Expense | 43 | 46 | 36 | 81 | 72 |
| Other Income | 110 | 177 | 234 | -1,716 | 148 |
| Pre-tax Income | -920 | -602 | -1,443 | -3,509 | -1,248 |
| Income Tax | -21 | -12 | 8 | 0 | -29 |
| Net Income Continuous | -899 | -590 | -1,450 | -3,509 | -1,220 |
| Minority Interests | 46 | 24 | 27 | 18 | 26 |
| Net Income | $-852 | $-566 | $-1,423 | $-3,491 | $-1,193 |
| EPS Basic Total Ops | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| EPS Diluted Total Ops | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| EBITDA(a) | $-648 | $-324 | $-1,199 | $-3,008 | $-1,005 |